Antiviral resistance mutations and genotype-associated amino acid substitutions in treatment-Naïve Hepatitis B virus-infected individuals from the Indian subcontinent

Intervirology

Volumn 55, Issue 1, 2011, Pages 36-44

  Ismail, A M ^a   Samuel, P ^a   Eapen, C E ^a   Kannangai, R ^a   Abraham, P ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Antiviral therapy; Drug resistance; Genotypes; Hepatitis B virus; Mutation; Reverse transcriptase

Indexed keywords

ADEFOVIR; ENTECAVIR; LAMIVUDINE;

ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; ANTIVIRAL RESISTANCE; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; INDIAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; VIRUS MUTANT; WILD TYPE;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; DRUG RESISTANCE, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; INDIA; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; RNA-DIRECTED DNA POLYMERASE; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

HEPATITIS B VIRUS;

EID: 80855156674     PISSN: 03005526     EISSN: 14230100     Source Type: Journal    
DOI: 10.1159/000323521     Document Type: Article

References (45)

1. Liaw YF, Gane E, Leung N, Zeuzem S, Wang Y, Lai CL, Heathcote EJ, Manns M, Bzowej N, Niu J, Han SH, Hwang SG, Cakaloglu Y, Tong MJ, Papatheodoridis G, Chen Y, Brown NA, Albanis E, Galil K, Naoumov NV: 2-year globe trial results: telbivudine is superior to lamivudine in patients with chronic hepatitis B. Gastroenterology 2009; 136: 486-495.
2. Tenney DJ, Rose RE, Baldick CJ, Pokornows-ki KA, Eggers BJ, Fang J, Wichroski MJ, Xu D, Yang J, Wilber RB, Colonno RJ: Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naive patients is rare through 5 years of therapy. Hepatology 2009; 49:1503-1514.
3. Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, Chang TT, Kitis G, Rizzetto M, Marcellin P, Lim SG, Goodman Z, Ma J, Brosgart CL, Borroto-Esoda K, Arterburn S, Chuck SL: Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years. Gastroenterology 2006; 131: 1743-1751. (Pubitemid 44958517)
4. Prevention of Hepatitis B in India-An Overview. New Delhi, World Health Organisation South-East Asia Regional Office, 2002.
5. Locarnini S, Mason WS: Cellular and viro-logical mechanisms of HBV drug resistance. J Hepatol 2006; 44: 422-431. (Pubitemid 43069226)
6. Stuyver LJ, Locarnini SA, Lok A, Richman DD, Carman WF, Dienstag JL, Schinazi RF: Nomenclature for antiviral-resistant human hepatitis B virus mutations in the poly-merase region. Hepatology 2001; 33: 751-757. (Pubitemid 32185239)
7. Bartholomeusz A, Tehan BG, Chalmers DK: Comparisons of the HBV and HIV poly-merase, and antiviral resistance mutations. Antivir Ther 2004; 9: 149-160. (Pubitemid 38560208)
8. Nowak MA, Bonhoeffer S, Hill AM, Boehme R, Thomas HC, McDade H: Viral dynamics in hepatitis B virus infection. Proc Natl Acad Sci USA 1996; 93: 4398-4402. (Pubitemid 26144299)
9. Fares MA, Holmes EC: A revised evolutionary history of hepatitis B virus (HBV). J Mol Evol 2002; 54:807-814. (Pubitemid 34553646)
10. Borroto-Esoda K, Miller MD, Arterburn S: Pooled analysis of amino acid changes in the HBV polymerase in patients from four major adefovir dipivoxil clinical trials. J Hepatol 2007; 47:492-498. (Pubitemid 47334760)
11. Allen MI, Deslauriers M, Andrews CW, Tipples GA, Walters KA, Tyrrell DL, Brown N, Condreay LD: Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group. Hepatology 1998; 27: 1670-1677. (Pubitemid 28264693)
12. Bartholomeusz A, Locarnini SA: Antiviral drug resistance: clinical consequences and molecular aspects. Semin Liver Dis 2006; 26: 162-170. (Pubitemid 43668258)
13. Tenney DJ, Levine SM, Rose RE, Walsh AW, Weinheimer SP, Discotto L, Plym M, Pokornowski K, Yu CF, Angus P, Ayres A, Bartholomeusz A, Sievert W, Thompson G, Warner N, Locarnini S, Colonno RJ: Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to lamivudine. Antimi-crob Agents Chemother 2004; 48:3498-3507. (Pubitemid 39129351)
14. Colonno RJ, Rose R, Baldick CJ, Levine S, Pokornowski K, Yu CF, Walsh A, Fang J, Hsu M, Mazzucco C, Eggers B, Zhang S, Plym M, Klesczewski K, Tenney DJ: Entecavir resistance is rare in nucleoside na ive patients with hepatitis B. Hepatology 2006; 44: 1656-1665. (Pubitemid 44953670)
15. Wakil SM, Kazim SN, Khan LA, Raisuddin S, Parvez MK, Guptan RC, Thakur V, Hasnain SE, Sarin SK: Prevalence and profile of mutations associated with lamivudine therapy in Indian patients with chronic hepatitis B in the surface and polymerase genes of hepatitis B virus. J Med Virol 2002; 68:311-318.
16. Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, Robertson BH, Locarnini S, Magnius LO: Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 2004; 47: 289-309. (Pubitemid 39541275)
17. Purdy MA, Talekar G, Swenson P, Araujo A, Fields H: A new algorithm for deduction of hepatitis B surface antigen subtype determinants from the amino acid sequence. Inter-virology 2007; 50:45-51. (Pubitemid 46005271)
18. Liu BM, Li T, Xu J, Li XG, Dong JP, Yan P, Yang JX, Yan L, Gao ZY, Li WP, Sun XW, Wang YH, Jiao XJ, Hou CS, Zhuang H: Characterization of potential antiviral resistance mutations in hepatitis B virus reverse tran-scriptase sequences in treatment-naive Chinese patients. Antiviral Res 2010; 85:512-519.
19. Han Y, Huang LH, Liu CM, Yang S, Li J, Lin ZM, Kong XF, Yu de M, Zhang DH, Jin GD, Lu ZM, Gong QM, Zhang XX: Characterization of hepatitis B virus reverse transcriptase sequences in Chinese treatment naive patients. J Gastroenterol Hepatol 2009; 24: 1417-1423.
20. Sayan M, Akhan SC, Meric M: Naturally occurring amino-acid substitutions to nucleos(t)ide analogues in treatment naive Turkish patients with chronic hepatitis B. J Viral Hepat 2010; 17: 23-27.
21. Pastor R, Habersetzer F, Fafi-Kremer S, Dof-foel M, Baumert TF, Gut JP, Stoll-Keller F, Schvoerer E: Hepatitis virus mutations potentially conferring adefovir/tenofovir resistance in treatment-naive patients. World J Gastroenterol 2009; 15:753-755.
22. Zhang D, Chen J, Deng L, Mao Q, Zheng J, Wu J, Zeng C, Li Y: Evolutionary selection associated with the multi-function of overlapping genes in the hepatitis B virus. Infect Genet Evol 2010; 10: 84-88.
23. Tamura K, Dudley J, Nei M, Kumar S: Mega4: Molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evol 2007; 24:1596-1599. (Pubitemid 47236692)
24. Lazarevic I, Cupic M, Delic D, Svirtlih NS, Simonovic J, Jovanovic T: Distribution of HBV genotypes, subgenotypes and HBsAg subtypes among chronically infected patients in Serbia. Arch Virol 2007; 152:2017-2025. (Pubitemid 350112297)
25. Lusida MI, Nugrahaputra VE, Soetjipto, Handajani R, Nagano-Fujii M, Sasayama M, Utsumi T, Hotta H: Novel subgenotypes of hepatitis B virus genotypes C and D in Papua, Indonesia. J Clin Microbiol 2008; 46: 2160-2166.
26. Ciancio A, Smedile A, Rizzetto M, Lagget M, Gerin J, Korba B: Identification of HBV DNA sequences that are predictive of response to lamivudine therapy. Hepatology 2004; 39: 64-73. (Pubitemid 38461468)
27. Bottecchia M, Madejon A, Sheldon J, Garcia-Samaniego J, Barreiro P, Soriano V: Hepatitis B virus genotype A2 harbours an L217R polymorphism which may account for a lower response to adefovir. J Antimicrob Che-mother 2008; 62: 626-627.
28. Solmone M, Vincenti D, Prosperi MC, Bruselles A, Ippolito G, Capobianchi MR: Use of massively parallel ultradeep pyrosequencing to characterize the genetic diversity of hepatitis B virus in drug-resistant and drug-naive patients and to detect minor variants in reverse transcriptase and hepatitis B S antigen. J Virol 2009; 83:1718-1726.
29. Vivekanandan P, Abraham P, Sridharan G, Chandy G, Daniel D, Raghuraman S, Daniel HD, Subramaniam T: Distribution of hepatitis B virus genotypes in blood donors and chronically infected patients in a tertiary care hospital in southern India. Clin Infect Dis 2004; 38:e81-e86.
30. Vivekanandan P, Daniel HD, Raghuraman S, Daniel D, Shaji RV, Sridharan G, Chandy G, Abraham P: Novel digestion patterns with hepatitis B virus strains from the Indian subcontinent detected using restriction fragment length polymorphism. Indian J Med Microbiol 2008; 26: 96-97. (Pubitemid 351197582)
31. Banerjee A, Datta S, Chandra PK, Roychowdhury S, Panda CK, Chakravarty R: Distribution of hepatitis B virus genotypes: phylo-genetic analysis and virological characteristics of genotype C circulating among HBV carriers in Kolkata, eastern India. World J Gastroenterol 2006; 12:5964-5971. (Pubitemid 44608474)
32. Banerjee A, Kurbanov F, Datta S, Chandra PK, Tanaka Y, Mizokami M, Chakravarty R: Phylogenetic relatedness and genetic diversity of hepatitis B virus isolates in eastern India. J Med Virol 2006; 78: 1164-1174. (Pubitemid 44182232)
33. Chandra PK, Biswas A, Datta S, Banerjee A, Panigrahi R, Chakrabarti S, De BK, Chakravarty R: Subgenotypes of hepatitis B virus genotype D (D1, D2, D3 and D5) in India: differential pattern of mutations, liver injury and occult HBV infection. J Viral Hepat 2009; 16:749-756.
34. Banerjee A, Chandra PK, Datta S, Biswas A, Bhattacharya P, Chakraborty S, Chakrabarti S, Bhattacharya SK, Chakravarty R: Frequency and significance of hepatitis B virus surface gene variant circulating among 'an-tiHBc only' individuals in eastern India. J Clin Virol 2007; 40:312-317. (Pubitemid 350151995)
35. Kumar GT, Kazim SN, Kumar M, Hissar S, Chauhan R, Basir SF, Sarin SK: Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection. J Gastroenterol Hepatol 2009; 24: 588-598.
36. Villet S, Pichoud C, Billioud G, Barraud L, Durantel S, Trepo C, Zoulim F: Impact of hepatitis B virus rtA181V/T mutants on hepatitis B treatment failure. J Hepatol 2008; 48: 747-755.
37. Schildgen O, Olotu C, Funk A, Zollner B, Helm M, Rockstroh JK, Sirma H: Selection and counterselection of the rtI233V adefovir resistance mutation during antiviral therapy. J Clin Microbiol 2010; 48:631-634.
38. Curtis M, Zhu Y, Borroto-Esoda K: Hepatitis B virus containing the I233V mutation in the polymerase reverse-transcriptase domain remains sensitive to inhibition by adefovir. J Infect Dis 2007; 196: 1483-1486. (Pubitemid 351411984)
39. Tan J, Degertekin B, Wong SN, Husain M, Oberhelman K, Lok AS: Tenofovir mono-therapy is effective in hepatitis B patients with antiviral treatment failure to adefovir in the absence of adefovir-resistant mutations. J Hepatol 2008; 48: 391-398.
40. Xiong X, Yang H, Westland CE, Zou R, Gibbs CS: In vitro evaluation of hepatitis B virus polymerase mutations associated with fam-ciclovir resistance. Hepatology 2000; 31:219-224.
41. Torresi J, Earnest-Silveira L, Civitico G, Walters TE, Lewin SR, Fyfe J, Locarnini SA, Manns M, Trautwein C, Bock TC: Restoration of replication phenotype of lamivudine-resistant hepatitis B virus mutants by compensatory changes in the 'Fingers' subdo-main of the viral polymerase selected as a consequence of mutations in the overlapping S gene. Virology 2002; 299:88-99. (Pubitemid 35007514)
42. Wallace WA, Carman WF: Surface variation of HBV: scientific and medical relevance. Viral hepatitis review 1997; 3:5-16.
43. Kazim SN, Chauhan R, Das BC, Sarin SK: Association of core promoter mutations with viral breakthrough in chronic hepatitis B patients on long-term lamivudine therapy. J Gastroenterol Hepatol 2006; 21:1525-1532. (Pubitemid 44266510)
44. Fukai K, Zhang KY, Imazeki F, Kurihara T, Mikata R, Yokosuka O: Association between lamivudine sensitivity and the number of substitutions in the reverse transcriptase region of the hepatitis B virus polymerase. J Viral Hepat 2007; 14: 661-666. (Pubitemid 47258265)
45. Ghany M, Liang TJ: Drug targets and molecular mechanisms of drug resistance in chronic hepatitis B. Gastroenterology 2007; 132: 1574-1585. (Pubitemid 46627588)